Back to Search Start Over

Air-liquid interphase culture confers SARS-CoV-2 susceptibility to A549 alveolar epithelial cells

Authors :
1000070609403
Sasaki, Michihito
Kishimoto, Mai
Itakura, Yukari
Tabata, Koshiro
Intaruck, Kittiya
Uemura, Kentaro
Toba, Shinsuke
Sanaki, Takao
Sato, Akihiko
Hall, William W.
1000060507169
Orba, Yasuko
1000030292006
Sawa, Hirofumi
1000070609403
Sasaki, Michihito
Kishimoto, Mai
Itakura, Yukari
Tabata, Koshiro
Intaruck, Kittiya
Uemura, Kentaro
Toba, Shinsuke
Sanaki, Takao
Sato, Akihiko
Hall, William W.
1000060507169
Orba, Yasuko
1000030292006
Sawa, Hirofumi
Publication Year :
2021

Abstract

The human lung cell A549 is susceptible to infection with a number of respiratory viruses. However, A549 cells are resistant to Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) infection in conventional submerged culture, and this would appear to be due to low expression levels of the SARSCoV-2 entry receptor: angiotensin-converting enzyme-2 (ACE2). Here, we examined SARS-CoV-2 susceptibility to A549 cells after adaptation to air-liquid interface (ALI) culture. A549 cells in ALI culture yielded a layer of mucus on their apical surface, exhibited decreased expression levels of the proliferation marker KI-67 and intriguingly became susceptible to SARS-CoV-2 infection. We found that A549 cells increased the endogenous expression levels of ACE2 and TMPRSS2 following adaptation to ALI culture conditions. Camostat, a TMPRSS2 inhibitor, reduced SARS-CoV-2 infection in ALI-cultured A549 cells. These findings indicate that ALI culture switches the phenotype of A549 cells from resistance to susceptibility to SARS-CoV-2 infection through upregulation of ACE2 and TMPRSS2. (c) 2021 Elsevier Inc. All rights reserved.

Details

Database :
OAIster
Notes :
application/pdf, English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1375179007
Document Type :
Electronic Resource